Pfizer Yields 6.8%, Trades at 8.5X Earnings, and Has a Promising Late-Stage Weight Loss Drug. Why Are So Many Investors Still Ignoring the Stock?
There is more to this stock than meets the eye.
Why it matters
Attributed market update with source link for portfolio context.